US Broker Ratings

Summit Therapeutics Inc. (SMMT) Stock Analysis: Promising 91% Upside in the Biotech Sector

Investors with an eye on the biotechnology sector might find Summit Therapeutics Inc. (NASDAQ: SMMT) an intriguing opportunity, given the significant potential upside of 91.42% as indicated by current analyst..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Robust Revenue Growth Offers 31.75% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) has been generating significant interest in the biotechnology sector, attracting investors with its innovative approach to B-cell mediated diseases. With a market capitalization of $5.4..

Exact Sciences Corporation (EXAS) Stock Analysis: Evaluating Growth in Cancer Diagnostics with a $20 Billion Market Cap

Exact Sciences Corporation (NASDAQ: EXAS) continues to capture investor attention with its robust standing in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Madison, Wisconsin, this..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A 24.79% Upside Potential Beckons Investors

Investors eyeing Takeda Pharmaceutical Company Limited (NYSE: TAK) will find a compelling narrative of potential growth amidst a robust healthcare sector. With a significant market capitalization of $52.51 billion, Takeda..

Insulet Corporation (PODD) Stock Analysis: A Healthcare Powerhouse with 86% Potential Upside

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector as a leading innovator in the medical devices industry, with a specific focus on insulin delivery systems. As the demand..

Legend Biotech Corporation (LEGN): Investor Outlook with a 142.62% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its promising biotechnology pipeline, particularly in the rapidly evolving field of oncology. With a market capitalization of $4.36..

Elevance Health, Inc. (ELV): Investor Outlook on a Healthcare Giant with a Solid Dividend Yield

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare sector, presents an intriguing opportunity for investors looking to gain exposure to the robust U.S. healthcare market. With a..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 31.36% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector, is capturing investor attention, not least due to its considerable potential upside of 31.36%. As a key entity in..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with a 31.44% Upside Potential

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, specifically within diagnostics and research, is garnering attention for its robust potential upside and strategic role in healthcare innovation...

Bio-Rad Laboratories, Inc. (BIO) Investor Outlook: Navigating the 11.58% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector with a focus on medical devices, offers an intriguing proposition for investors seeking exposure to the life sciences and..

McKesson Corporation (MCK) Stock Analysis: Exploring a Potential 21.73% Upside Amid Robust Revenue Growth

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to solidify its position as a leading provider of medical distribution services. With a market capitalization of $99.71 billion,..

Option Care Health, Inc. (OPCH) Investor Outlook: Evaluating a 53% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, particularly in the medical care facilities industry, presents an intriguing investment opportunity with a compelling potential upside..

Charles River Laboratories (CRL) Stock Report: Analyst Consensus and 20% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. This Massachusetts-based company is known for its..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a Promising 11.54% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), an innovative player in the biotechnology sector, is catching investor attention with its promising growth trajectory and a potential upside of 11.54%. Headquartered in Dublin,..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: A 33.82% Upside Potential Beckons in the Biotech Sector

Ionis Pharmaceuticals, Inc. (IONS), a key player in the biotechnology sector, is commanding attention from investors with a market cap of $12.44 billion. Known for its pioneering RNA-targeted medicines, Ionis..

Vertex Pharmaceuticals (VRTX) Stock Report: Analyzing a 29.33% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a beacon in the biotechnology sector, with a market capitalization of $107.83 billion. Known for its groundbreaking treatments for serious diseases, Vertex has..

Insmed Incorporated (INSM): Analyst Consensus Signals a Potential 59.61% Upside for Investors

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline of therapies for serious and rare diseases. With..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 39.59% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian powerhouse in the healthcare industry, stands out as a compelling investment opportunity with a notable potential upside of 39.59%. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 9.04% Upside Amidst Healthcare Sector Dynamics

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, remains a focal point for investors seeking exposure in the medical instruments and supplies industry. With a market capitalization..

Waystar Holding Corp. (WAY) Stock Analysis: A 68% Upside Potential Awaits Investors

Waystar Holding Corp. (NASDAQ: WAY), a burgeoning player in the healthcare information services sector, presents an intriguing opportunity for investors seeking growth in the tech-driven healthcare domain. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds